Chronic liver disorders known as autoimmune liver diseases emerge from dysfunctional immune system activity. Patients develop autoantibodies which attack liver tissues causing hepatocellular injury and bile duct inflammation as part of their immune response to these disorders. Early detection and quick treatment prevent liver disease from advancing into cirrhosis and liver failure. Creative Diagnostics provides a complete range of biomarker testing solutions for the detection of specific serum autoantibodies which assist in clinical diagnosis and facilitate disease monitoring as well as treatment evaluation.
Autoimmune Hepatitis Markers
Primary Biliary Cholangitis (PBC) Markers
We have integrated a variety of advanced testing technologies and established a complete testing system:
| Detection Method | Application Purpose |
| Indirect Immunofluorescence (IIF) | Qualitative screening and titer determination of autoantibodies with visual pattern analysis |
| ELISA | Quantitative antibody detection suitable for high-throughput screening |
| Western Blot | Verification of specific antigen-antibody reactions with high specificity |
| Enzyme Immunodot Assay | Detection of low-concentration antibodies with high sensitivity |
| Immunoturbidimetry | Rapid quantification of specific serum proteins with simple operation |
| Protein Microarray | Simultaneous multi-parameter detection with high throughput capability |
Service Features
Sample Requirements
We offer flexible customization including:
For more information or consultation about specific testing solutions, please contact our technical support team. Creative Diagnostics will provide professional advice and customized solutions based on your specific requirements.
